BioRegenx

BioRegenx is a regenerative medicine company dedicated to the science of the endothelial glycocalyx, the micro-thin lining of the entire vascular system. The company integrates advanced diagnostic technology with targeted nutritional therapy to assess and improve microvascular health. Its flagship diagnostic tool, GlycoCheck, is a non-invasive system that measures the health of the glycocalyx, while its patented supplement, Endocalyx Pro, provides the building blocks necessary for its repair and maintenance. BioRegenx operates as a holding company for several subsidiaries focused on commercializing these microvascular health solutions globally. By targeting the root cause of vascular decline, the company aims to address conditions such as cardiovascular disease, kidney dysfunction, and diabetic complications.